Literature DB >> 20566227

Fractionation in prostate cancer--is it time after all?

Michael Baumann, Tobias Hölscher, Jim Denham.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20566227     DOI： 10.1016/j.radonc.2010.06.001

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


× No keyword cloud information.
  5 in total

Review 1.  Meta-analysis of the alpha/beta ratio for prostate cancer in the presence of an overall time factor: bad news, good news, or no news?

Authors:  Ivan R Vogelius; Søren M Bentzen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-05-30       Impact factor: 7.038

Review 2.  Hypofractionated radiotherapy for localized prostate cancer.

Authors:  Stefan Höcht; Daniel M Aebersold; Clemens Albrecht; Dirk Böhmer; Michael Flentje; Ute Ganswindt; Tobias Hölscher; Thomas Martin; Felix Sedlmayer; Frederik Wenz; Daniel Zips; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2016-09-14       Impact factor: 3.621

Review 3.  Protons, Photons, and the Prostate - Is There Emerging Evidence in the Ongoing Discussion on Particle Therapy for the Treatment of Prostate Cancer?

Authors:  Kilian C Schiller; Gregor Habl; Stephanie E Combs
Journal:  Front Oncol       Date:  2016-01-28       Impact factor: 6.244

4.  Efficacy of PSMA ligand PET-based radiotherapy for recurrent prostate cancer after radical prostatectomy and salvage radiotherapy.

Authors:  Ann-Kathrin Oehus; Stephanie G C Kroeze; Nina-Sophie Schmidt-Hegemann; Marco M E Vogel; Simon Kirste; Jessica Becker; Irene A Burger; Thorsten Derlin; Peter Bartenstein; Matthias Eiber; Michael Mix; Christian la Fougère; Claus Belka; Stephanie E Combs; Anca-Ligia Grosu; Arndt-Christian Müller; Matthias Guckenberger; Hans Christiansen; Christoph Henkenberens
Journal:  BMC Cancer       Date:  2020-04-29       Impact factor: 4.430

Review 5.  Ultrahypofractionation of localized prostate cancer : Statement from the DEGRO working group prostate cancer.

Authors:  Frank Wolf; Felix Sedlmayer; Daniel Aebersold; Clemens Albrecht; Dirk Böhmer; Michael Flentje; Ute Ganswindt; Pirus Ghadjar; Stefan Höcht; Tobias Hölscher; Arndt-Christian Müller; Peter Niehoff; Michael Pinkawa; Nina-Sophie Schmidt-Hegemann; Constantinos Zamboglou; Daniel Zips; Thomas Wiegel
Journal:  Strahlenther Onkol       Date:  2020-12-10       Impact factor: 3.621
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.